New drug shows promise for diabetic kidney damage in Mid-Stage trial

NCT ID NCT05718375

Completed Disease control Sponsor: Curacle Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new drug called CU01-1001 in 240 adults with type 2 diabetes and early kidney damage (albuminuria). Participants took the drug or a placebo for 24 weeks to see if it could reduce protein leakage in urine, a sign of kidney health. The goal is to find a treatment that helps control diabetic kidney disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic kidney disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC NEPHROPATHIES

Contacts and locations

Locations

Ajou University Hospital

Gyeonggi-do, South Korea
Daegu Catholic University Medical Center

Daegu, South Korea
Daejeon Eulji Medical Center, Eulji University

Daejeon, South Korea
Gachon University Gil Medical Center

Incheon, South Korea
Hallym University Dongtan Sacred Heart Hospital

Gyeonggi-do, South Korea
Hallym University Gangnam Sacred Heart Hospital

Seoul, South Korea
Jeonbuk National University Hospital

Jeonju, South Korea
Kangbuk Samsung Hospital

Seoul, South Korea
Keimyung University Dongsan Hospital

Daegu, South Korea
Korea University Ansan Hospital

Gyeonggi-do, South Korea
Korea University Guro Hospital

Seoul, South Korea
Kyung Hee University Hospital

Seoul, South Korea
Kyungpook National University Chilgok Hospital

Daegu, South Korea
Nowon Eulji University

Seoul, South Korea
Pusan National University Hospital

Busan, South Korea
Samsung Medical Center

Seoul, South Korea
Seoul National University Bundang Hospital

Gyeonggi-do, South Korea
Seoul National University Hospital

Seoul, South Korea
Severance Hospital

Seoul, South Korea
SoonChunHyang University Hospital Cheonan

Chuncheon, South Korea
The Catholic University of Korea Bucheon St. Mary's Hospital

Gyeonggi-do, South Korea
The Catholic University of Korea Seoul St. Mary's Hospital

Seoul, South Korea
Wonju Severance Christian Hospital

Wŏnju, South Korea
Yeongnam University Medical Center

Daegu, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.